| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 77, 56-60, Copyright © 1993 by Endocrine Society
ARTICLES |
SM Haffner, RA Valdez, PA Morales, HP Hazuda and MP Stern
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7873.
Sex hormones may influence risk factors for noninsulin-dependent diabetes mellitus (NIDDM). Decreased sex hormone-binding globulin (SHBG; an indirect measure of androgenicity) is associated with hyperinsulinemia and insulin resistance. We measured SHBG concentrations in 58 subjects who later converted to diabetes and 107 subjects who remained normoglycemic throughout the 8 yr of follow-up of the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. Among premenopausal women, SHBG concentrations (nanomoles per L) were significantly lower in converters than in nonconverters (41.6 +/- 12.4 vs. 74.4 +/- 10.0; P = 0.004), but corresponding differences were not observed in postmenopausal women or in men. Since, however, analysis of variance suggested no significant interaction between menopausal status and conversion to NIDDM, we pooled pre- and postmenopausal women. Subsequent analysis indicated that SHBG concentrations predicted the development of NIDDM in women independently of glucose and insulin concentrations. We conclude that increased androgenicity, as assessed by decreased SHBG concentrations, is an important independent risk factor for NIDDM in women.
This article has been cited by other articles:
![]() |
B. Sternfeld, K. Liu, C. P. Quesenberry Jr., H. Wang, S.-F. Jiang, M. Daviglus, M. Fornage, C. E. Lewis, J. Mahan, P. J. Schreiner, et al. Changes over 14 Years in Androgenicity and Body Mass Index in a Biracial Cohort of Reproductive-Age Women J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2158 - 2165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wu, M. C. Yu, C.-C. Tseng, F. Z. Stanczyk, and M. C. Pike Diabetes and risk of breast cancer in Asian-American women Carcinogenesis, July 1, 2007; 28(7): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Golden, A. S. Dobs, D. Vaidya, M. Szklo, S. Gapstur, P. Kopp, K. Liu, and P. Ouyang Endogenous Sex Hormones and Glucose Tolerance Status in Postmenopausal Women J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1289 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Ding, Y. Song, V. S. Malik, and S. Liu Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis JAMA, March 15, 2006; 295(11): 1288 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sutton-Tyrrell, R. P. Wildman, K. A. Matthews, C. Chae, B. L. Lasley, S. Brockwell, R. C. Pasternak, D. Lloyd-Jones, M. F. Sowers, J. I. Torrens, et al. Sex Hormone-Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN) Circulation, March 15, 2005; 111(10): 1242 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kalme, M. Seppala, Q. Qiao, R. Koistinen, A. Nissinen, M. Harrela, M. Loukovaara, P. Leinonen, and J. Tuomilehto Sex Hormone-Binding Globulin and Insulin-Like Growth Factor-Binding Protein-1 as Indicators of Metabolic Syndrome, Cardiovascular Risk, and Mortality in Elderly Men J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1550 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Golden, J. Ding, M. Szklo, M. I. Schmidt, B. B. Duncan, and A. Dobs Glucose and Insulin Components of the Metabolic Syndrome Are Associated with Hyperandrogenism in Postmenopausal Women: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., September 15, 2004; 160(6): 540 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Thadhani, J. L. Ecker, W. P. Mutter, M. Wolf, K. V. Smirnakis, V. P. Sukhatme, R. J. Levine, and S. A. Karumanchi Insulin Resistance and Alterations in Angiogenesis: Additive Insults That May Lead to Preeclampsia Hypertension, May 1, 2004; 43(5): 988 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Tsai, A. M. Matsumoto, W. Y. Fujimoto, and E. J. Boyko Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance: Influence of sex hormone-binding globulin and body fat Diabetes Care, April 1, 2004; 27(4): 861 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cousin, L. Calemard-Michel, H. Lejeune, G. Raverot, N. Yessaad, A. Emptoz-Bonneton, Y. Morel, and M. Pugeat Influence of SHBG Gene Pentanucleotide TAAAA Repeat and D327N Polymorphism on Serum Sex Hormone-Binding Globulin Concentration in Hirsute Women J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Rexrode, J. E. Manson, I-M. Lee, P. M Ridker, P. M. Sluss, N. R. Cook, and J. E. Buring Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women Circulation, October 7, 2003; 108(14): 1688 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sowers, C. Derby, M. L. Jannausch, J. I. Torrens, and R. Pasternak Insulin Resistance, Hemostatic Factors, and Hormone Interactions in Pre- and Perimenopausal Women: SWAN J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4904 - 4910. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jayagopal, E. S. Kilpatrick, P. E. Jennings, D. A. Hepburn, and S. L. Atkin The Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin Resistance J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1528 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Kalish, E. Barrett-Connor, G. A. Laughlin, and B. I. Gulanski Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1646 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cibula, J. Skrha, M. Hill, M. Fanta, L. Haakova, J. VrbIkova, and J. Zivny Prediction of Insulin Sensitivity in Nonobese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5821 - 5825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolf, L. Sandler, R. Jimenez-Kimble, A. Shah, J. L. Ecker, and R. Thadhani Insulin Resistance But Not Inflammation Is Associated With Gestational Hypertension Hypertension, December 1, 2002; 40(6): 886 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolf, L. Sandler, K. Munoz, K. Hsu, J. L. Ecker, and R. Thadhani First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1563 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res, February 15, 2002; 53(3): 538 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Andersson, G. Johannsson, G. Holm, B.-A. Bengtsson, A. Sashegyi, I. Pavo, T. Mason, and P. W. Anderson Raloxifene Does Not Affect Insulin Sensitivity or Glycemic Control in Postmenopausal Women with Type 2 Diabetes Mellitus: A Randomized Clinical Trial J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 122 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Oh, E. Barrett-Connor, N. M. Wedick, and D. L. Wingard Endogenous Sex Hormones and the Development of Type 2 Diabetes in Older Men and Women: the Rancho Bernardo Study Diabetes Care, January 1, 2002; 25(1): 55 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Solomon, F. B. Hu, A. Dunaif, J. Rich-Edwards, W. C. Willett, D. J. Hunter, G. A. Colditz, F. E. Speizer, and J. E. Manson Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus JAMA, November 21, 2001; 286(19): 2421 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger Premature Adrenarche--Normal Variant or Forerunner of Adult Disease? Endocr. Rev., December 1, 2000; 21(6): 671 - 696. [Abstract] [Full Text] |
||||
![]() |
C. Couillard, J. Gagnon, J. Bergeron, A. S. Leon, D. C. Rao, J. S. Skinner, J. H. Wilmore, J.-P. Després, and C. Bouchard Contribution of Body Fatness and Adipose Tissue Distribution to the Age Variation in Plasma Steroid Hormone Concentrations in Men: The HERITAGE Family Study J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1026 - 1031. [Abstract] [Full Text] |
||||
![]() |
L. Ibanez, N. Potau, M. Zampolli, S. RiquE, P. Saenger, and A. Carrascosa Hyperinsulinemia and Decreased Insulin-Like Growth Factor-Binding Protein-1 Are Common Features in Prepubertal and Pubertal Girls with a History of Premature Pubarche J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2283 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Andersson, L.-A. Mattsson, L. Hahn, L. Lapidus, G. Holm, B.-A. Bengtsson, and P. Bjorntorp Estrogen Replacement Therapy Decreases Hyperandrogenicity and Improves Glucose Homeostasis and Plasma Lipids in Postmenopausal Women With Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 638 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Simon, M.-A. Charles, K. Nahoul, G. Orssaud, J. Kremski, V. Hully, E. Joubert, L. Papoz, and E. Eschwege Association between Plasma Total Testosterone and Cardiovascular Risk Factors in Healthy Adult Men: The Telecom Study J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 682 - 685. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |